Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 4,820,970	$ 5,327,016
Accounts receivable, net	4,965,381	4,307,726
Inventory, net	3,134,237	2,973,134
Other current assets	519,624	287,528
Assets held for sale	5,941,933	649,884
Current assets - discontinued operations	0	95,861
Total current assets	19,382,145	13,641,149
Property and equipment, net	1,227,880	7,000,015
Right of use assets, operating leases, net	15,779	28,519
Right of use assets, finance leases, net	364,379	436,403
Tradenames and other unamortizable intangible assets	217,000	217,000
Total assets	21,207,183	21,323,086
Current liabilities
Accounts payable and accrued liabilities	4,090,153	6,252,951
Accrued separation costs, related parties, current portion	334,532	463,911
Accrued interest	91,251	95,942
Deferred revenue	886,787	1,312,837
Stock appreciation rights liability	731,181	255,020
Notes payable - current portion	125,259	121,041
Lease liability - operating leases, current	14,898	17,131
Lease liability - finance leases, current	151,984	115,738
Current liabilities - discontinued operations	0	6,422
Total current liabilities	6,426,045	8,640,993
Note payable, net of discount	8,436,849	8,855,000
Accrued separation costs, related parties, non-current	541,025	791,025
Lease liability - operating leases, non-current	881	11,388
Lease liability - finance leases, non-current	46,942	219,266
Total liabilities	15,451,742	18,517,672
Commitments & Contingencies (see Note 18)	0	0
Stockholders' equity
Common stock: $0.0001 par value; 500,000,000 shares authorized; 53,977,782 and 52,538,100 shares issued, and 51,133,485 and 49,714,929 shares outstanding at September 30, 2024 and December 31, 2023, respectively	5,395	5,251
Additional paid-in capital	43,055,316	42,762,811
Treasury stock: 2,644,297 and 2,623,171 shares outstanding at September 30, 2024 and December 31, 2023, respectively	(1,141,372)	(1,141,370)
Accumulated deficit	(36,163,898)	(38,821,278)
Total stockholders' equity	5,755,441	2,805,414
Total liabilities and stockholders' equity	$ 21,207,183	$ 21,323,086

Liability arising from stock appreciation rights.

No definition available.

Name:	ivfh_StockAppreciationRightsLiability
Namespace Prefix:	ivfh_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.